Safety and Efficacy of Ianalumab in Patients With Sj?gren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study

待确认 10 由上上签发布于 2026/6/18 16:15:36

DOI:10.1002/art.43059
作者：Thomas D?rner,?Simon J. Bowman,?Robert Fox,?Xavier Mariette,?Athena Papas,?Thomas Grader-Beck,?Benjamin A. Fisher,?Filipe Barcelos,?Salvatore De Vita,?Hendrik Schulze-Koops,?Robert J. Moots,?Guido Jun
文献类型：期刊论文
补充材料：只需要正文

Wiley

Abstract： Objective The objective of this study was to report 52-week safety and efficacy of ianalumab from phase 2b dose-findin

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

17小时前

hxie

f09571666aee11f1ace134735aa3bc31.pdf

17小时前

Book学术机器人

2026/6/18 16:15:37 未找到该文献，机器人已退出，请等待人工下载

2026/6/18 16:15:36 Book学术AI机器人收到请求，开始寻找文献

2026/6/18 16:15:36 已向机器人发送请求

17小时前

上上签发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierMulti-Plate tectonics in Western Gondwana: Insights from structural overprints and kinematic interactions within the Central African fold belt (CAFB)